Cargando…

Pharmacokinetic analysis of linezolid for multidrug resistant tuberculosis at a tertiary care centre in Mumbai, India

Linezolid is an oxazolidinone used to treat multidrug-resistant tuberculosis (MDR-TB), including in the recently-endorsed shorter 6-month treatment regimens. Due to its narrow therapeutic index, linezolid is often either dose-adjusted or discontinued due to intolerance or toxicity during treatment,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Resendiz-Galvan, Juan Eduardo, Arora, Prerna R., Abdelwahab, Mahmoud Tareq, Udwadia, Zarir F., Rodrigues, Camilla, Gupta, Amita, Denti, Paolo, Ashavaid, Tester F., Tornheim, Jeffrey A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846493/ https://www.ncbi.nlm.nih.gov/pubmed/36686664 http://dx.doi.org/10.3389/fphar.2022.1081123

Ejemplares similares

Increased Moxifloxacin Dosing Among Patients With Multidrug-Resistant Tuberculosis With Low-Level Resistance to Moxifloxacin Did Not Improve Treatment Outcomes in a Tertiary Care Center in Mumbai, India
por: Tornheim, Jeffrey A, et al.
Publicado: (2021)

Clinical features associated with linezolid resistance among multidrug resistant tuberculosis patients at a tertiary care hospital in Mumbai, India
por: Tornheim, J.A., et al.
Publicado: (2020)

Few eligible for the newly recommended short course MDR-TB regimen at a large Mumbai private clinic
por: Udwadia, Zarir F., et al.
Publicado: (2019)

Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis
por: Tornheim, Jeffrey A., et al.
Publicado: (2022)

Linezolid resistance in Mycobacterium tuberculosis isolates at a tertiary care centre in Mumbai, India
por: Nambiar, Remya, et al.
Publicado: (2021)

Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai
por: Udwadia, Zarir F, et al.
Publicado: (2016)

Multidrug-resistant-tuberculosis treatment in the Indian private sector: Results from a tertiary referral private hospital in Mumbai
por: Udwadia, Zarir F., et al.
Publicado: (2014)

Tuberculosis Management by Private Practitioners in Mumbai, India: Has Anything Changed in Two Decades?
por: Udwadia, Zarir F., et al.
Publicado: (2010)

Swimming against the STREAM: Why STREAM 2 data cannot be easily applied to MDR-TB patients across India
por: Udwadia, Zarir F., et al.
Publicado: (2023)

Effective use of telemedicine in Mumbai with a cohort of extensively drug-resistant “XDR” tuberculosis patients on bedaquiline during COVID-19 pandemic
por: Udwadia, Zarir F., et al.
Publicado: (2021)

Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis
por: Zhang, Haoyue, et al.
Publicado: (2023)

Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India
por: Mehta, Salil, et al.
Publicado: (2016)

Who will teach the teachers: An analysis of the inhaler technique of Indian patients and health care providers in a tertiary health care centre
por: Mullerpattan, Jai Bharat, et al.
Publicado: (2016)

Children and Multidrug-Resistant Tuberculosis in Mumbai (Bombay), India
por: Karande, Sunil, et al.
Publicado: (2002)

Intrathecal/Intraventricular Linezolid in Multidrug-Resistant Enterococcus faecalis Ventriculitis
por: Lich, Brian F., et al.
Publicado: (2016)

Low Rate of Acquired Linezolid Resistance in Multidrug-Resistant Tuberculosis Treated With Bedaquiline-Linezolid Combination
por: Du, Jian, et al.
Publicado: (2021)

Disseminated tuberculosis with immune thrombocytopenic purpura
por: Dagaonkar, Rucha S., et al.
Publicado: (2012)

India should speed up access to bedaquiline-based all-oral regimens, not procrastinate further
por: Udwadia, Zarir F, et al.
Publicado: (2021)

Tropical pulmonary eosinophilia - A review
por: Mullerpattan, Jai B., et al.
Publicado: (2013)

A Review of Population Pharmacokinetic Analyses of Linezolid
por: Bandín-Vilar, Enrique, et al.
Publicado: (2022)

Shortcomings on genetic testing of Familial hypercholesterolemia (FH) in India: Can we collaborate to establish Indian FH registry?
por: Reddy, Lakshmi Lavanya, et al.
Publicado: (2022)

Adverse Events among HIV/MDR-TB Co-Infected Patients Receiving Antiretroviral and Second Line Anti-TB Treatment in Mumbai, India
por: Isaakidis, Petros, et al.
Publicado: (2012)

Experience with pediatric sarcoidosis at a centre in Mumbai, India
por: Khubchandani, RP, et al.
Publicado: (2011)

Private patient perceptions about a public programme; what do private Indian tuberculosis patients really feel about directly observed treatment?
por: Pinto, Lancelot M, et al.
Publicado: (2010)

The N-95 mask: Invaluable ally in the battle against the COVID-19 pandemic
por: Udwadia, Zarir F., et al.
Publicado: (2020)

How to protect the protectors: 10 lessons to learn for doctors fighting the COVID-19 coronavirus
por: Udwadia, Zarir F., et al.
Publicado: (2020)

New treatments for Drug Resistant TB: Past imperfect, future bright
por: Udwadia, Zarir F., et al.
Publicado: (2023)

Low-Dose Linezolid for Treatment of Patients With Multidrug-Resistant Tuberculosis
por: Mase, Anjeli, et al.
Publicado: (2022)

Pharmacokinetics of Linezolid and Ertapenem in experimental parapneumonic pleural effusion
por: Saroglou, Maria, et al.
Publicado: (2010)

Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
por: Estes, Kerry S, et al.
Publicado: (2010)

Effects of a rifampicin pre-treatment on linezolid pharmacokinetics
por: Okazaki, Fumiyasu, et al.
Publicado: (2019)

Linezolid-resistant Enterococcus (LRE) faecium from Blood Culture of an Adult Burns Patient: First Report of LRE from Mumbai
por: Baveja, Sujata M, et al.
Publicado: (2017)

Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies
por: Garcia-Prats, Anthony J., et al.
Publicado: (2019)

Quality of drug-resistant tuberculosis care: Gaps and solutions
por: Udwadia, Zarir, et al.
Publicado: (2019)

Pharmacokinetics of linezolid in critically ill patients undergoing continuous venovenous hemofiltration
por: Meyer, B, et al.
Publicado: (2004)

Oxaliplatin-induced lung fibrosis
por: Shah, Arpan, et al.
Publicado: (2009)

Favipiravir: A new and emerging antiviral option in COVID-19
por: Agrawal, Umang, et al.
Publicado: (2020)

Thiopurine metabolite level and toxicity in Indians with inflammatory bowel disease
por: Parkar, Suruchi P, et al.
Publicado: (2017)

Physiologically-Based Pharmacokinetic Modelling to Predict the Pharmacokinetics and Pharmacodynamics of Linezolid in Adults and Children with Tuberculous Meningitis
por: Litjens, Carlijn H. C., et al.
Publicado: (2023)

Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Greater Metropolitan Mumbai: Trends over Time
por: Dalal, Alpa, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t6l6jnshk4imoqq65n3vkvbfbs